Possible agent for COVID-19 treatment: Rifampicin

Rifampicin is a promising drug for the treatment of coronavirus disease 2019 based on its antiviral properties and recent studies. studies can serve as a foundation for further studies.

Saved in:
Bibliographic Details
Published inWorld journal of virology Vol. 11; no. 5; pp. 391 - 393
Main Authors Aydin, Ozlem Celik, Aydın, Sonay, Barun, Sureyya
Format Journal Article
LanguageEnglish
Published United States Baishideng Publishing Group Inc 25.09.2022
Subjects
Letter to the Editor
COVID-19
In silico
Rifampicin
Treatment
Drug-drug interaction
Therapeutic potential
Online AccessGet full text

Cover

More Information
Summary:Rifampicin is a promising drug for the treatment of coronavirus disease 2019 based on its antiviral properties and recent studies. studies can serve as a foundation for further studies.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author contributions: Aydın S, Aydin OC and Barun S conceived the study; Aydın S, Aydin OC and Barun S were responsible for designing, materials and supervision; Aydın S, Aydin OC and Barun S did the literature search, wrote the manuscript, and reviewed the manuscript critically; All authors have read and approved the final manuscript.
Corresponding author: Ozlem Celik Aydin, MD, Doctor, Department of Medical Pharma-cology, Erzincan University, Mengucek Gazi Education and Research Hospital, Başbağlar Mahallesi Hacı Ali Akın Caddesi No. 32 Erzincan/Merkez, Erzincan 24100, Turkey. ozlemclk_89@hotmail.com
ISSN:2220-3249
2220-3249
DOI:10.5501/wjv.v11.i5.391